Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Gut peptide receptors in pancreata of azaserine-treated and normal control rats

Publication files not online:

Author: Tang, C. · Biemond, I. · Appel, M.J. · Visser, C.J.T. · Woutersen, R.A. · Lamers, C.B.H.W.
Type:article
Date:1995
Institution: Centraal Instituut voor Voedingsonderzoek TNO
Source:Carcinogenesis, 12, 16, 2951-2956
Identifier: 37106
Keywords: Biology · Animals · Azaserine · Pancreas · Pancreatic Neoplasms · Rats · Rats, Wistar · Receptors, Peptide

Abstract

Gut peptides are involved in the growth and carcinogenesis of the exocrine pancreas of rats after treatment with azaserine. However, little is known about the influence of azaserine on expression of gut peptide receptors in the pancreas of the rat. Cholecystokinin, bombesin, somatostatin, secretin and vasoactive intestinal peptide receptors were therefore visualized and quantified by storage phosphor autoradiography in pancreata of either saline control or azaserine-treated rats. As expected, putative preneoplastic lesions were formed in the pancreata of the azaserine-treated but not in the control animals. The pancreata of control rats contained receptors for cholecystokinin, bombesin, somatostatin, secretin and vasoactive intestinal peptide. Cholecystokinin receptors were of the A-type and showed, in contrast to the other receptors, a heterogeneous expression due to variability of the high-affinity receptors. In the pancreata of azaserine-treated animals a significantly increased binding capacity of high-affinity receptors for cholecystokinin was found not only in atypical acinar cell nodules but also in non-nodular pancreas when compared to pancreas of control rats (P < 0.05). Neither atypical acinar cell nodules nor non-nodular pancreas of rats treated by azaserine were shown to possess receptors for the other four types of gut peptide receptors. The spectrum of peptide receptors in pancreas of control and azaserine-treated rats in this study may help to understand the mechanism whereby gut hormones may modulate pancreatic carcinogenesis.